Shengshou Hu Selected Research

Length of Stay

1/2023	Tranexamic acid is associated with improved hemostasis in elderly patients undergoing coronary-artery surgeries in a retrospective cohort study.
9/2014	[Feasibility of transcatheter closure of atrial septal defect under the guidance of transthoracic echocardiography].
2/2014	[Effects of multidisciplinary blood management strategy on transfusion and outcomes in patients undergoing valvular heart surgery].
3/2013	A retrospective clinical study of transaortic extended septal myectomy for obstructive hypertrophic cardiomyopathy in China.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shengshou Hu Research Topics

Disease

29	Myocardial Infarction 11/2023 - 02/2006
16	Heart Failure 05/2024 - 04/2011
16	Coronary Artery Disease (Coronary Atherosclerosis) 11/2023 - 11/2010
10	Hemorrhage 11/2023 - 08/2003
9	Stroke (Strokes) 11/2023 - 03/2006
9	Hypoxia (Hypoxemia) 01/2022 - 02/2006
8	Congenital Heart Defects (Congenital Heart Defect) 01/2019 - 12/2011
7	Acute Kidney Injury (Acute Renal Failure) 11/2023 - 06/2011
7	Fibrosis (Cirrhosis) 10/2023 - 01/2011
7	Inflammation (Inflammations) 03/2023 - 03/2013
7	Cardiomyopathies (Cardiomyopathy) 01/2022 - 05/2013
7	Thrombosis (Thrombus) 01/2019 - 08/2003
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 08/2006
6	Atrial Fibrillation 01/2022 - 02/2002
6	Heart Diseases (Heart Disease) 01/2022 - 06/2011
5	Hypertension (High Blood Pressure) 10/2023 - 02/2014
5	Infarction (Infarctions) 01/2020 - 02/2006
5	Ischemia 03/2013 - 09/2009
4	Hypertrophy 08/2013 - 04/2008
4	Mitochondrial Diseases (Mitochondrial Disease) 05/2013 - 02/2006
3	Arrhythmogenic Right Ventricular Dysplasia (Arrhythmogenic Right Ventricular Cardiomyopathy) 01/2024 - 01/2016
3	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2023 - 04/2011
3	Cardiogenic Shock 02/2019 - 06/2011
3	Pulmonary Arterial Hypertension 01/2019 - 01/2011
3	Pulmonary Hypertension 01/2017 - 01/2011
3	Renal Insufficiency (Renal Failure) 12/2016 - 03/2013
3	Reperfusion Injury 01/2016 - 12/2012
3	Patent Ductus Arteriosus 07/2015 - 05/2011
3	Pathologic Processes 01/2015 - 09/2012
3	Hemolysis 01/2014 - 06/2011
3	Ventricular Remodeling 10/2013 - 04/2008
2	Cardiomegaly (Heart Hypertrophy) 11/2023 - 08/2013
2	Aortic Dissection 05/2023 - 03/2006
2	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2023 - 11/2022
2	Obesity 12/2020 - 01/2015
2	Left Ventricular Outflow Obstruction 11/2020 - 09/2014
2	Shock 02/2019 - 01/2019
2	Right Ventricular Hypertrophy 01/2019 - 11/2013
2	Diabetes Mellitus 06/2016 - 06/2014
2	Wounds and Injuries (Trauma) 07/2015 - 01/2015
2	Body Weight (Weight, Body) 01/2015 - 09/2014
2	Postoperative Hemorrhage 11/2014 - 10/2009
2	Ventricular Heart Septal Defects (Ventricular Septal Defect) 09/2014 - 05/2010
2	Cicatrix (Scar) 10/2013 - 02/2006
2	Myocardial Ischemia (Ischemic Heart Diseases) 12/2012 - 01/2012
2	Aortic Valve Insufficiency (Aortic Regurgitation) 11/2010 - 09/2005

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 03/2023 - 03/2006
7	MicroRNAs (MicroRNA)IBA 01/2017 - 01/2009
4	RNA (Ribonucleic Acid)IBA 01/2024 - 10/2021
4	CytokinesIBA 03/2023 - 06/2011
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2023 - 08/2006
4	lysophosphatidic acidIBA 08/2013 - 01/2008
3	C-Reactive ProteinIBA 03/2023 - 10/2012
3	Clopidogrel (Plavix)FDA Link 01/2023 - 11/2010
3	LipidsIBA 12/2020 - 09/2012
3	Messenger RNA (mRNA)IBA 11/2016 - 04/2008
3	Biomarkers (Surrogate Marker)IBA 12/2014 - 08/2012
3	SolutionsIBA 11/2014 - 05/2010
3	Lysophosphatidic Acid ReceptorsIBA 08/2013 - 01/2008
3	AldehydesIBA 02/2013 - 07/2012
2	Interleukin-6 (Interleukin 6)IBA 03/2023 - 10/2015
2	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2023 - 01/2021
2	Antihypertensive Agents (Antihypertensives)IBA 01/2023 - 02/2014
2	CreatinineIBA 01/2022 - 12/2020
2	Glucose (Dextrose)FDA LinkGeneric 03/2021 - 12/2020
2	Anti-Arrhythmia AgentsIBA 01/2019 - 07/2014
2	Connexin 43 (Connexin43)IBA 01/2017 - 01/2015
2	MonocrotalineIBA 01/2017 - 01/2014
2	Contrast MediaIBA 07/2015 - 01/2015
2	Clostridium perfringens epsilon-toxinIBA 03/2015 - 01/2015
2	Oxygen (Dioxygen)IBA 01/2015 - 11/2013
2	urinastatin (MR 20)IBA 01/2015 - 03/2013
2	Coloring Agents (Dyes)IBA 05/2014 - 02/2006
2	LuciferasesIBA 08/2013 - 04/2008
2	Cytochromes c (Cytochrome c)IBA 11/2010 - 02/2006

Therapy/Procedure

21	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2023 - 02/2002
12	Therapeutics 05/2024 - 08/2008
10	Cardiopulmonary Bypass (Heart-Lung Bypass) 09/2021 - 06/2011
9	Transplantation 01/2022 - 02/2006
7	Percutaneous Coronary Intervention 11/2023 - 12/2012
6	Heart Transplantation (Grafting, Heart) 11/2023 - 05/2012
6	Off-Pump Coronary Artery Bypass (Coronary Artery Bypass, Off Pump) 11/2023 - 09/2008
5	Blood Transfusion (Blood Transfusions) 11/2023 - 04/2010
4	Length of Stay 01/2023 - 03/2013
3	Extracorporeal Membrane Oxygenation 02/2019 - 06/2011
3	Intra-Aortic Balloon Pumping 02/2019 - 03/2013
3	Cannula 04/2017 - 02/2013
3	Arterial Switch Operation 08/2016 - 11/2010
3	Ligation 10/2011 - 02/2006
2	Heart-Assist Devices 05/2024 - 01/2017
2	Renal Replacement Therapy (Therapies, Renal Replacement) 05/2023 - 01/2013
2	Thoracotomy 09/2021 - 01/2019
2	Secondary Prevention 01/2021 - 02/2016
2	Radiofrequency Ablation 01/2019 - 07/2014
2	Ischemic Postconditioning 01/2016 - 01/2012
2	Stents 01/2016 - 03/2011
2	Intravenous Administration 03/2013 - 03/2011
2	Cell- and Tissue-Based Therapy (Cell Therapy) 03/2012 - 01/2008
2	Lasers (Laser) 06/2011 - 05/2011
2	Drug-Eluting Stents 01/2011 - 04/2009